Voltar
Artigo Revisado por pares
BIBTEX RIS

Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials

2022; Lippincott Williams & Wilkins; Volume: 41; Issue: 7 Linguagem: Inglês

10.1200/jco.22.01064

ISSN

1527-7755

Autores

Olivia Pagani, Barbara Walley, Gini F. Fleming, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Harold J. Burstein, Matthew P. Goetz, Eva Ciruelos, Vered Stearns, Hervé Bonnefoi, Silvana Martino, Charles E. Geyer, Claudio Chini, Fabio Puglisi, Simon Spazzapan, Thomas Ruhstaller, Eric P. Winer, Barbara Ruepp, Sherene Loi, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan, Prudence A. Francis,

Tópico(s)

Breast Cancer Treatment Studies

Resumo

JCO

Referência(s)